Providence Capital Advisors, LLC Boston Scientific Corp Transaction History

Providence Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$40.9 - $45.1 $3.94 Million - $4.35 Million	-96,410 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$38.07 - $44.87 $525,746 - $619,654	13,810 Added 16.72%	96,410 $4.1 Million
Q3 2021 Nov 09, 2021	BUY	$41.23 - $45.88 $3.41 Million - $3.79 Million	82,600 New	82,600 $3.58 Million
Q1 2018 May 10, 2018	SELL	$25.2 - $28.54 $1.76 Million - $2 Million	-70,000 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$24.79 - $29.8 $1.74 Million - $2.09 Million	70,000	70,000 $1.74 Million

1,543

1.19B

6.79M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Providence Capital Advisors, LLC with notifications on news.